Table 1. Sociodemographic Characteristics, Sexual Behavior Characteristics, HIV, and Human papillomavirus (HPV) infection Characteristics of 1262 Multicenter AIDS Cohort Study Participants Evaluated for HPV DNA using Anal Swab Specimens.
HIV Seropositive | HIV Seronegative | Total | |
(N = 579) | (N = 683) | (N = 1262) | |
n (%) | n (%) | n (%) | |
Characteristic | |||
Age (years) | |||
<30 | 4 (01) | 9 (01) | 13 (01) |
30–39 | 31 (05) | 34 (05) | 65 (05) |
40–49 | 154 (27) | 108 (16) | 262 (21) |
50–59 | 280 (48) | 277 (41) | 557 (44) |
60–69 | 101 (17) | 203 (30) | 304 (24) |
70–80 | 9 (02) | 48 (07) | 57 (05) |
>80 | 0 (00) | 4 (01) | 4 (<1) |
Race a | |||
Black/African American | 148 (25.6) | 70 (10.3) | 218 (17.3) |
Caucasian/White | 405 (70.0) | 588 (86.1) | 993 (78.7) |
Asian | 3 (<1.0) | 7 (01.0) | 10 (<1.0) |
Other | 23 (04.0) | 18 (02.6) | 41 (03.3) |
Ethnicity | |||
Hispanicb | 56 (09.7) | 44 (06.4) | 100 (07.9) |
Smoking | |||
Ever Smoked MACS Visit 1 to 24 months before HPV testing | |||
Yes | 427 (73.8) | 486 (71.2) | 913 (72.4) |
No | 152 (26.2) | 197 (28.8) | 349 (27.6) |
Ever Smoked within last 24 months before HPV testing c | |||
Yes | 189 (32.6) | 123 (18.0) | 312 (24.7) |
No | 390 (67.4) | 560 (82.0) | 950 (75.3) |
AIDS Defining Illnessesd | |||
None | 486 (83.9) | – | – |
Kaposi’s Sarcoma | 17 (02.9) | – | – |
Pneumocystis Pneumonia | 26 (04.5) | – | – |
Non-Hodgkin’s Lymphoma | 1 (00.2) | – | – |
Wasting Syndrome | 15 (02.6) | – | – |
HPV-DNA Prevalence | |||
None | 54 (09.3) | 203 (29.7) | 257 (20.4) |
≥1 HPV Type | 525 (90.7) | 480 (70.3) | 1005 (79.6) |
IARC HPV Carcinogenicity Classification | |||
Group 1, strong carcinogens | 396 (68) | 306 (45) | 702 (56) |
Group 2, weaker carcinogens | 255 (44) | 186 (27) | 441 (35) |
Lower Risk | 445 (77) | 322 (47) | 767 (61) |
HPV 16 or 18 | 180 (31.1) | 139 (20.4) | 319 (25.3) |
HPV 16 | 133 (23.0) | 109 (15.9) | 242 (19.2) |
HPV 18 | 69 (11.9) | 40 (05.9) | 109 (08.6) |
p<0.001, b p = 0.037, c p<0.001, dcategories are not mutually exclusive, e p = 0.062; f p = 0.138 g p<0.001. P-values for comparing HIV+ vs. HIV- were by the Fisher exact test or the Wilcoxon nonparametric test, as appropriate.